Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Farah Al-Sahlawi"'
Publikováno v:
Pharmacia, Vol 71, Iss , Pp 1-12 (2024)
Background: Gefitinib (GEF) is a tyrosine kinase inhibitor that has proven good efficacy against Non-small cell Lung Carcinoma (NSCLC). It has low solubility and dissolution rate and low oral bioavailability. This work aimed to improve efficacy by lo
Externí odkaz:
https://doaj.org/article/14dc9029158a4086b146d986ec6b684a
